Compound ID | 2696
Class: Protein synthesis inhibitor
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor. Inhibits aminoacyl-tRNA formation by directly interacting with the tRNA inactivating its capacity to be aminoacylated |
| Target Pathogen: | Active against Staphylococcus aureus, MDR Staphylococcus aureus, Streptococcus haemolyticus, Streptococcus pneumoniae, Clostridium perfringens, Proteus vulgaris, and Escherichia coli |
| Description: | Natural product from Actinoplanes ianthinogenes; contains naphthazarin and isocoumarin moieties; has very poor solubility, binds to proteins, and inactivated in serum |
| Institute where first reported: | Research Laboratories, Gruppo Lepetit S. p. A., Via Durando, 38, Milano, Italy |
| Year first mentioned: | 1974 |
| Development status: | Experimental |